Kristin Lynn Eckel-Mahan

Title: Kristin Lynn Eckel-Mahan: Innovator in Obesity Treatment

Introduction

Kristin Lynn Eckel-Mahan is a prominent inventor based in Irvine, CA. She has made significant contributions to the field of obesity treatment through her innovative research and patent work. Her dedication to addressing obesity-related disorders has led to advancements in pharmacological approaches.

Latest Patents

Kristin holds a patent titled "Treatment of obesity and obesity related disorders by pharmacological targeting of Kv1.3 potassium channels." This patent focuses on the activation of brown adipose tissue and the treatment of obesity and related disorders in both human and non-human animal subjects. The method involves administering a potassium channel inhibiting agent, which may include ShK toxin or modified versions such as ShK-186.

Career Highlights

Throughout her career, Kristin has worked with esteemed institutions, including the University of California and Kineta One, LLC. Her work has been instrumental in advancing the understanding and treatment of obesity through innovative scientific approaches.

Collaborations

Kristin has collaborated with notable professionals in her field, including K George Chandy and Sanjeev Kumar Upadhayay. These collaborations have further enriched her research and contributed to her success as an inventor.

Conclusion

Kristin Lynn Eckel-Mahan is a trailblazer in the field of obesity treatment, with a focus on innovative pharmacological solutions. Her contributions through her patent and collaborations highlight her commitment to improving health outcomes related to obesity.